Clinical Trials on Light Chain (AL) Amyloidosis
Total 156 results
-
Peking Union Medical College HospitalRecruitingLight Chain (AL) Amyloidosis | Venetoclax | CCND1 TranslocationChina
-
Tufts Medical CenterSanofiWithdrawnAmyloidosis | Light Chain (AL) Amyloidosis
-
Alfred Chung, MDAbbVie; Janssen PharmaceuticalsRecruitingAL Amyloidosis | Light Chain (AL) Amyloidosis | Systemic Light Chain DiseaseUnited States
-
Nanjing University School of MedicineRecruiting
-
Nexcella Inc.Not yet recruitingLight Chain (AL) AmyloidosisUnited States
-
Sorrento Therapeutics, Inc.RecruitingLight Chain (AL) AmyloidosisUnited States
-
Sorrento Therapeutics, Inc.WithdrawnLight Chain (AL) Amyloidosis
-
Air Force Military Medical University, ChinaNot yet recruitingImmunoglobulin Light-chain Amyloidosis
-
European Myeloma NetworkJanssen PharmaceuticaActive, not recruitingLight Chain (AL) Amyloidosis, Stage 3BNetherlands, Greece, France, Italy
-
Florian MichelGerman Federal Ministry of Education and ResearchCompletedLight Chain (AL) Amyloidosis | Cardiac InvolvementGermany
-
Millennium Pharmaceuticals, Inc.CompletedLight-Chain AmyloidosisUnited States, Canada, France, Germany, Italy
-
Prothena Biosciences Ltd.RecruitingLight Chain (AL) AmyloidosisUnited States, Korea, Republic of, Australia, Denmark, France, Italy, Spain, Israel, Taiwan, Austria, Canada, Czechia, Germany, Greece, Hungary, Japan, Netherlands, Poland, Portugal, Turkey, United Kingdom, Belgium, Ireland
-
Criterium, Inc.AmgenCompletedAmyloidosis | Systemic Light Chain AmyloidosisUnited States
-
IRCCS Policlinico S. MatteoTerminatedPrimary Amyloidosis of Light Chain TypeItaly
-
IRCCS Policlinico S. MatteoCompletedPrimary Amyloidosis of Light Chain TypeItaly
-
AbbVieRecruitingImmunoglobulin Light Chain (AL) AmyloidosisJapan
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedAmyloidosis | Light Chain Deposition Disease (LCDD or MIDD) | Light Chain and Heavy Chain Deposition Disease (LHCDD or MIDD) | Monoclonal Immunoglobulin Deposition Disease (MIDD)United States
-
Weill Medical College of Cornell UniversityJanssen Scientific Affairs, LLCRecruitingAL Amyloidosis | Amyloid | Refractory AL AmyloidosisUnited States
-
IRCCS Policlinico S. MatteoTerminatedCardiac AL AmyloidosisSpain, France, Italy, Germany, Canada, Greece, Turkey, United Kingdom
-
TakedaCompletedMultiple Myeloma | Immunoglobulin Light-chain AmyloidosisSpain
-
Millennium Pharmaceuticals, Inc.TerminatedRelapsed or Refractory Systemic Light Chain AmyloidosisUnited States, Canada, Spain, Israel, France, Australia, Denmark, Germany, Korea, Republic of, Greece, Netherlands, Brazil, Czechia, Italy, United Kingdom
-
Jin Lu, MDRecruiting
-
University of TennesseeFDA Office of Orphan Products DevelopmentCompleted
-
Mayo ClinicRecruitingAL AmyloidosisUnited States
-
Intergroupe Francophone du MyelomeBristol-Myers Squibb; SanofiRecruiting
-
European Myeloma NetworkGlaxoSmithKlineRecruitingAL AmyloidosisGermany, Netherlands, France, Greece, Italy, United Kingdom
-
Tufts Medical CenterTerminatedAL AmyloidosisUnited States
-
Columbia UniversityCephalonCompletedAL AmyloidosisUnited States
-
Prothena Biosciences Ltd.TerminatedAL AmyloidosisUnited States, Spain, Australia, Italy, Germany, Austria, Greece, France, Israel, United Kingdom
-
European Myeloma NetworkCompleted
-
Guangdong Provincial People's HospitalRecruitingImmunoglobulin Light-Chain AmyloidosisChina
-
University Hospital, LimogesMinistry of Health, FranceCompletedPrimary Systemic Amyloidosis (AL)France
-
Jin Lu, MDRecruitingAL Amyloidosis | Amyloidosis; SystemicChina
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnAmyloidosis | Immunoglobulin Light Chain Deposition
-
IRCCS Policlinico S. MatteoRecruitingAL AmyloidosisGermany, Italy, Spain, Switzerland, Netherlands
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)Not yet recruiting
-
Rajshekhar Chakraborty, MDGenentech, Inc.RecruitingAL AmyloidosisUnited States
-
University of Texas Southwestern Medical CenterGlaxoSmithKlineRecruitingAL Amyloidosis | AmyloidosisUnited States
-
IRCCS Policlinico S. MatteoRecruiting
-
National Cancer Institute (NCI)Recruiting
-
Emory UniversityNational Cancer Institute (NCI); SanofiRecruitingAL AmyloidosisUnited States
-
IRCCS Policlinico S. MatteoRecruiting
-
Alexion Pharmaceuticals, Inc.CompletedAL AmyloidosisUnited States
-
Memorial Sloan Kettering Cancer CenterVanderbilt University Medical Center; Tufts Medical CenterActive, not recruiting
-
Oncopeptides ABPRA Health SciencesTerminatedAL AmyloidosisSpain, United Kingdom, Germany, Norway, Israel, France, United States, Czechia, Greece
-
University Hospital, LimogesCompletedAmyloidosisFrance, Italy
-
University College, LondonCompleted
-
Boston Medical CenterCelgene CorporationCompletedAL AmyloidosisUnited States
-
Boston Medical CenterTerminatedAL AmyloidosisUnited States
-
University of TennesseeCompleted